Tyra Biosciences (TYRA)
(Real Time Quote from BATS)
$15.55 USD
+0.44 (2.91%)
Updated Apr 26, 2024 11:16 AM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Tyra Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -69.13 | -55.33 | -26.29 | -9.34 | NA |
Depreciation/Amortization & Depletion | 0.35 | 0.30 | 0.14 | 0.05 | NA |
Net Change from Assets/Liabilities | 6.36 | -5.85 | -0.48 | 1.07 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 12.28 | 10.59 | 2.89 | 0.46 | NA |
Net Cash From Operating Activities | -50.14 | -50.29 | -23.75 | -7.76 | NA |
Property & Equipment | -0.77 | -0.56 | -0.65 | -0.31 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | -143.84 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -144.61 | -0.56 | -0.65 | -0.31 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.54 | 0.63 | 311.36 | 23.45 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.01 | -0.02 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 1.54 | 0.63 | 311.35 | 23.43 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -193.21 | -50.21 | 286.96 | 15.36 | NA |
Cash at Beginning of Period | 252.21 | 302.43 | 15.47 | 0.11 | NA |
Cash at End of Period | 59.01 | 252.21 | 302.43 | 15.47 | NA |
Diluted Net EPS | -1.62 | -1.32 | -1.91 | NA | NA |
Fiscal Year End for Tyra Biosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -69.13 | -46.30 | -25.15 | -11.88 |
Depreciation/Amortization & Depletion | NA | 0.35 | 0.25 | 0.17 | 0.08 |
Net Change from Assets/Liabilities | NA | 6.36 | 0.10 | 0.56 | -0.48 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 12.28 | 9.34 | 4.97 | 2.43 |
Net Cash From Operating Activities | NA | -50.14 | -36.61 | -19.46 | -9.85 |
Property & Equipment | NA | -0.77 | -0.17 | -0.08 | -0.04 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -143.84 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -144.61 | -0.17 | -0.08 | -0.04 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.54 | 1.21 | 0.75 | 0.38 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 1.54 | 1.21 | 0.75 | 0.38 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -193.21 | -35.56 | -18.80 | -9.51 |
Cash at Beginning of Period | NA | 252.21 | 252.21 | 252.21 | 252.21 |
Cash at End of Period | NA | 59.01 | 216.65 | 233.41 | 242.70 |
Diluted Net EPS | NA | -0.54 | -0.49 | -0.31 | -0.28 |